Developing effective therapies for immunological diseases remains a major challenge due to the complexity of the immune system and limitations in traditional preclinical models. Many promising drug candidates fail in clinical trials due to a lack of predictive accuracy in existing in vitro and in vivo models.
This whitepaper examines how advanced 3D tissue models can improve translational relevance in immunology drug discovery, addressing key challenges in diseases such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).
Key Topics Covered:
- The biggest challenges in immunology drug discovery – and how to overcome them
- Breakthrough 3D tissue models for vascular inflammation, IBD, and CKD research
- Case studies showcasing real-world applications in immunology drug testing
- How advanced microphysioloigical systems improve therapeutic efficacy predictions
- How 3D human tissue models can enhance drug screening and mechanistic insights.
Download the Whitepaper to Access the Latest Findings & Case Studies!
